Zeke Capital Advisors’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $46.9K | Hold |
15,633
| – | – | ﹤0.01% | 464 |
|
|
2022
Q3 | $85K | Hold |
15,633
| – | – | 0.01% | 451 |
|
|
2022
Q2 | $70K | Hold |
15,633
| – | – | ﹤0.01% | 467 |
|
|
2022
Q1 | $139K | Hold |
15,633
| – | – | 0.01% | 496 |
|
|
2021
Q4 | $138K | Hold |
15,633
| – | – | 0.01% | 298 |
|
|
2021
Q3 | $178K | Hold |
15,633
| – | – | 0.01% | 282 |
|
|
2021
Q2 | $263K | Buy |
15,633
+12,500
| +399% | +$210K | 0.02% | 256 |
|
|
2021
Q1 | $113K | Hold |
3,133
| – | – | 0.01% | 283 |
|
|
2020
Q4 | $130K | Buy |
+3,133
| New | +$130K | 0.01% | 273 |
|